Developing vaccines to protect against avian influenza H5N1.
Advanced Development of Vaccines for Influenza
['FUNDING_OTHER'] · GREFFEX, INC. · NIH-11250855
This study is working on new vaccines to protect people from the H5N1 bird flu virus, and it's for anyone interested in helping us be ready for possible outbreaks by making sure these vaccines are safe and effective.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GREFFEX, INC. (nih funded) |
| Locations | 1 site (AURORA, UNITED STATES) |
| Trial ID | NIH-11250855 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing vaccines specifically for the avian influenza H5N1 virus, which poses a significant threat to public health. The approach involves formulating vaccine components and conducting rigorous testing in animal models to evaluate their safety and effectiveness. The research also includes preparing for clinical trials to assess the vaccines in humans, ensuring they are safe and can provide immunity against the virus. By advancing these vaccine candidates, the research aims to enhance our preparedness for potential outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for avian influenza exposure, such as healthcare workers and those in close contact with poultry.
Not a fit: Patients who are not at risk for avian influenza or those with existing immunity to the virus may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect against avian influenza H5N1, potentially saving lives during outbreaks.
How similar studies have performed: Previous research has shown promise in developing vaccines for other strains of influenza, indicating potential success for this approach.
Where this research is happening
AURORA, UNITED STATES
- GREFFEX, INC. — AURORA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STAERZ, UWE — GREFFEX, INC.
- Study coordinator: STAERZ, UWE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Disease Outbreaks